FNY Investment Advisers »

Palisade Bio shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Palisade Bio (PALI) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Palisade Bio

Tip: Access up to 7 years of quarterly data

All positions including Palisade Bio held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palisade Bio by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $23k 10k 2.31

More positions owned by FNY Investment Advisers

Cidara Therapeutics (CDTX)
Bank Of Montreal Cadcom (BMO)
Amplify Etf Tr (SILJ)
UnitedHealth (UNH)
Global X Fds global x copper (COPX)
Monolithic Power Systems (MPWR)
Morgan Stanley (MS)
Codere Online Luxembourg Ord (CDRO)
NVIDIA Corporation (NVDA)
Vaneck Vectors Gold Miners mutual (GDX)
Philip Morris International (PM)
Bleichroeder Acquisition Cor (BACQ)
Deere & Company (DE)
Futurecrest Acquisition Corp
Norfolk Southern (NSC)

View all positions for FNY Investment Advisers

Top funds holding Palisade Bio

Vanguard Group
UBS Group
Total Clarity Wealth Management
Two Sigma Securities
Geode Capital Management
XTX Topco
Newbridge Financial Services Group
FNY Investment Advisers
Tower Research Capital
Rockefeller Capital Management
Efficient Wealth Management
Federation des caisses Desjardins du Quebec
Wells Fargo & Company

View all funds holding Palisade Bio